DICER1: A Promising Drug Target and Biomarker for Helicase-Induced Dicer Family

Target Name: DICER1

NCBI ID: G23405

DICER1

DICER1: A Promising Drug Target and Biomarker for Helicase-Induced Dicer Family

Introduction

Helicase-induced cleavage enzymes (HI-Cas) are a class of cleavage enzymes widely found in bacteria and archaea and are of great significance to the origin and evolution of life. These enzymes can cleave double-stranded DNA, making it possible to repair DNA damage and recombine genes. In recent years, with the development of gene editing technology, HI-Cas has attracted widespread attention in the fields of drug research and biomedicine. However, despite some progress in drug screening and biomedical research, HI-Cas, as a complex enzyme, still faces high research and application difficulties.

DICER1: a potential drug target

DICER1 (DICER-1 complex endonuclease 1) is an RNA-dependent cleavage enzyme belonging to the HI-Cas family and is widely present in bacteria and archaea. Compared with HI-Cas2, DICER1 has lower cleavage efficiency but can cleave double-stranded DNA under mild conditions. DICER1 is conserved in the genomes of bacteria and archaea, which provides the possibility to study the application of HI-Cas in biomedicine.

The research significance of DICER1 as a drug target

1. Drug screening: As an efficient cutting enzyme, DICER1 can be used as a target for drug screening. By targeting DICER1 with pharmaceutical intervention, compounds with potential therapeutic effects can be screened. In addition, the high efficiency and mild cleavage conditions of DICER1 provide new possibilities for drug screening.

2. Gene therapy: The application of DICER1 in gene therapy also has great potential. By regulating the activity of DICER1, the efficacy of gene therapy can be improved and the success rate of treatment can be increased. In addition, the cleavage efficiency of DICER1 is of great significance in gene therapy because it can cleave foreign DNA, making it possible to implement gene therapy.

3. Biomedical research: As an important member of the HI-Cas family, DICER1 is of great significance in biomedical research. By studying the structure, function and substrate specificity of DICER1, we can gain an in-depth understanding of the molecular mechanism of the HI-Cas family and provide a new theoretical basis for drug research and biomedical research.

4. Drug research and development: As an efficient cutting enzyme, DICER1 provides new possibilities for drug research and development. Through drug intervention targeting DICER1, compounds with potential therapeutic effects can be screened out, providing new tools for drug development.

Summarize

As a potential drug target, DICER1 is of great significance in drug screening, gene therapy, biomedical research and drug development. Although current research on DICER1 has made some progress, it still faces many challenges. Therefore, future research should focus on in-depth study of the structure, function and substrate specificity of DICER1 to provide a new theoretical basis for the development of DICER1 and bring new hope to human health.

Protein Name: Dicer 1, Ribonuclease III

Functions: Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them or prevent their translation. Gene silencing mediated by siRNAs, also called RNA interference, controls the elimination of transcripts from mobile and repetitive DNA elements of the genome but also the degradation of exogenous RNA of viral origin for instance. The miRNA pathway on the other side is a mean to specifically regulate the expression of target genes

The "DICER1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DICER1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets